Clinical and haemodynamic study of atenolol (Tenormin) in essential hypertension. 1976

H A Jensen, and K Rasmussen, and N Mosbaek

1. The beta1-adrenoreceptor-blocking agent atenolol was studied in the treatment of twelve out-patients with essential hypertension. 2. With a mean dose of 110 mg of atenolol daily (range 75-200 mg/day) we observed a pronounced decrease in blood pressure. 3. Only minimal side effects were seen. 4. Cardiac output decreased from 4-6 to 3-4 l/min during treatment. This decrease did not correlate with the decrease in blood pressure but correlated well with the changes in calculated total peripheral resistance.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011412 Propanolamines AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. Aminopropanols
D002302 Cardiac Output The volume of BLOOD passing through the HEART per unit of time. It is usually expressed as liters (volume) per minute so as not to be confused with STROKE VOLUME (volume per beat). Cardiac Outputs,Output, Cardiac,Outputs, Cardiac
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001262 Atenolol A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect. ICI-66082,Tenormin,Tenormine,ICI 66082,ICI66082

Related Publications

H A Jensen, and K Rasmussen, and N Mosbaek
January 1984, JPMA. The Journal of the Pakistan Medical Association,
H A Jensen, and K Rasmussen, and N Mosbaek
January 1982, Vutreshni bolesti,
H A Jensen, and K Rasmussen, and N Mosbaek
December 1977, Polski tygodnik lekarski (Warsaw, Poland : 1960),
H A Jensen, and K Rasmussen, and N Mosbaek
February 1982, The Medical letter on drugs and therapeutics,
H A Jensen, and K Rasmussen, and N Mosbaek
December 1993, British journal of clinical pharmacology,
H A Jensen, and K Rasmussen, and N Mosbaek
January 1982, Critical care nurse,
H A Jensen, and K Rasmussen, and N Mosbaek
January 1976, The Journal of international medical research,
H A Jensen, and K Rasmussen, and N Mosbaek
December 1980, MMW, Munchener medizinische Wochenschrift,
H A Jensen, and K Rasmussen, and N Mosbaek
September 1978, East African medical journal,
Copied contents to your clipboard!